Inspire IVF Targets Middle East Domination: Eyes Saudi & UAE Partnerships, Capitalizing on Growing Healthcare Demand
Bangkok, 31 March 2025 – Inspire IVF Public Company Limited (Inspire IVF), a leading fertility center renowned for its international standards, is strategically expanding its business into the Middle East. This move underscores the company's commitment to forging business alliances and investing in high-potential markets like Saudi Arabia (KSA) and the United Arab Emirates (UAE). This expansion is driven by the increasing demand for fertility treatments and favorable healthcare policies in both countries, which prioritize public health development and investment in healthcare infrastructure. Inspire IVF aims to establish strategic partnerships to support its global growth, seize revenue opportunities, and deliver sustainable returns to investors and stakeholders.
Ms. Kasinee Kuldiloke, Chief Executive Officer of Inspire IVF Public Company Limited, stated, "Inspire IVF is pursuing a strategic Joint Venture approach to expand our business opportunities into the high-potential markets of Saudi Arabia (KSA) and the United Arab Emirates (UAE). We've observed a continuous surge in demand for fertility treatments, particularly In Vitro Fertilization (IVF), driven by factors such as delayed marriage and childbearing, coupled with proactive healthcare policies in both nations. For example, the Saudi government is investing over US$224 billion in developing its public health infrastructure. Furthermore, the UAE's health tourism market is valued at over AED 992 million (approximately US$270 million) and is poised to become a leading Medical Tourism Hub in the future."
“To ensure the successful execution of our expansion plan, we have engaged with key strategic partners and organizations, including integrated healthcare providers in the Middle East with expertise in pharmaceuticals, medical devices, and home healthcare services. These entities are interested in exploring potential collaborations to establish IVF centers in Saudi Arabia. We have also connected with regulatory bodies overseeing medical free zones in the UAE, which offer attractive incentives for healthcare investors, such as tax exemptions, full ownership rights, and infrastructure support for medical investments. These incentives will enable Inspire IVF to expand its business in the UAE effectively and efficiently," added Kasinee.
"The global IVF market is projected to reach US$43.57 billion by 2033, with a compound annual growth rate (CAGR) of 5.57% from 2024 to 2033 (Source: Vision Research Reports). This growth is fueled by the rising rates of infertility and advancements in IVF technology, leading to continuously improving success rates. This presents a significant opportunity for Inspire IVF to become a leading international standard fertility center in Thailand and Asia, fulfilling every dream of parenthood with simplicity and making it a reality (Simplicity in Every Step). We are committed to executing our expansion plan in the Middle East, investing in new technologies, and forging strategic partnerships to increase our market share and generate sustainable returns for our investors and stakeholders," Kasinee concluded.
Follow Inspire IVF Public Company Limited (IVF) for the latest updates on our website at www.inspireivf.com/ and our Facebook page at www.facebook.com/inspireivfthailand. For further information, please contact us at 063-531-8666 or 02-251-8666.
